Biopharmaceutical Pipelines and Facility Needs are Changing… Are You Prepared?

IBC's 2nd Annual Flexible Facilities conference brings together senior level executives and scientists from biopharmas, CMO's, technology providers, engineering firms and regulatory groups to explore the changing landscape of biologics manufacturing and to share case studies of the latest flexible facility implementations, lessons learned and practical experiences.

Prepare Your Facilities and Bioprocesses for a Changing Market: 

• Rapid Deployment/Emerging Regions
• More Complex & Diverse Molecules
• Facility Designs to Save Time and money
• Make Stainless Steel More Flexible
• Implementation of Single-Use
• Mobile and Modular Concepts
• Multi-product/Multi-use Facilities
• Regulatory Views & Technology Gaps

To learn more, download the 2014 brochure.

This event sold out last year. If you are interested in attending, you can take advantage of the lowest rates available – this is a $600 standard rate savings when you register by November 15 with priority code FLEX14LA1. For any additional questions, visit our website:

If you have questions about the event, contact Kate Devery (Kdevery@iirusa.com), or visit our webpage. We look forward to seeing you February 24-25 in Berkeley, California!

Cheers,
The Future of Biopharma Team

Flexible Facilities Webpage
Follow us on Twitter
Flexible Facilities LinkedIn

Share this article with your social network, just click below to share now!

Share |

Develop Scalable Bioprocesses for Cell Therapies with Cell Therapy Bioprocessing 2013!

The cell therapy industry has certainly come along way over the last two years. For 2013, our focus at Cell Therapy Bioprocessing, we're focusing on developing scalable bioprocesses as the cell therapy industry moves from discovery towards large-scale production.

Overcome Regulatory, Financial, Process Development and Manufacturing Hurdles and learn more about:

• - Regulatory Panel Discussion on Commercial Implications and Harmonization
• - Strategies to Develop Serum-Free Media
• - Techniques to Utilize High-Throughput, Automated Technology Platforms
• - QbD Approaches for Effective Process Characterization and Validation
• - Immunotherapeutic Methods to Target Cancer
• - Solutions to Commercially Viable Immunotherapy Bioprocessing
• - Bioengineering Approaches to Control Cell Fate Post Transplantation
• - Strategies for Successful Tech Transfer, Process and Equipment Changes
• - Process Optimization for Efficient Cell Therapy Manufacturing

How are companies working to overcome the challenges above?  Download the 2013 agenda today!

Want to join us at Cell Therapy Bioprocessing this coming October 21-22, 2013 in Bethesda, Maryland?  As  a reader of this blog, when you register to join us and mention code B13188JP20, you'll save 20% off the standard rate! Have any questions? Feel free to reach out to Jennifer Pereira.

Share this article with your social network, just click below to share now!

Share |

A Special Message from the Cell Based Assays & Bioanalytical Method Development Chairperson

A message from Shan Chung, PhD; Scientist, Bioanalytical Sciences, Genentech; Co-Chair, Cell Based Assays and BioAnalytical Method Development 2011:

Dear Colleague,

We all face similar challenges in designing and validating assays and bioprocesses. Whether trying to secure cell sources that reliably present conditions of interest, determining criteria to identify and eliminate outlier results, or designing assays sensitive enough to track ultra low-abundance proteins, each step involves performance trade-offs that must be carefully considered and accounted for. And ultimately we all seek to design methods with proven transferability and clinical utility.

That is why I would like to invite you to attend IIR’s 7th Annual Cell Based Assays and BioAnalytical Method Development conference, to be held October 3-5, 2011 at the Claremont Hotel Club & Spa in Berkeley, CA. This year’s event will feature nearly 40 speakers, and will continue to offer the small-format discussions and troubleshooting sessions you have come to expect. To learn more, download the latest conference brochure.

Some of the topics we will cover include:
• Strategies for control and assessment of Fc effector functions of therapeutic antibodies
• A rapid approach to developing reporter cell lines for bioassays
• Bioanalytical test elements that facilitate comparability studies for the development of biosimilars
• Virus neutralization assays using multiple image-based technology platforms

For more information, download the event brochure.

Thank you very much, and I look forward to welcoming you to this event in October.

Sincerely,
Shan Chung, PhD
Scientist, Bioanalytical Sciences, Genentech
Co-Chair, Cell Based Assays and BioAnalytical Method Development 2011

As a reader of the Future of Biopharma Blog, register for this event with the special Priority Code XP1668Blog, to receive 25% off the standard rate! If you have any questions about the event, please feel free to contact Jennifer Pereira at jpereira@iirusa.com. Register by emailing register@iirusa.com.

Share this article with your social network, just click below to share now!

Share |

The growing importance of biobanking

Jennifer Benner and Erik Koenig of BioProcess International recently wrote a piece focusing on the growing importance of biobanking. Much of this is due to the growing importance of well maintained samples that are growing due to the growing trend of personal health. Due to the growing rate, is it important that companies outsource this process? Read the full article here.

Share this article with your social network, just click below to share now!

Share |